Surmodics

$54.52 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Surmodics

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Stock Analysis

last close $54.52
1-mo return -2.5%
3-mo return 0.8%
avg daily vol. 40.02T
52-week high 62.27
52-week low 35.17
market cap. $762M
forward pe 84
annual div. -
roe 1.2%
ltg forecast -
dividend yield -
annual rev. $104M
inst own. 91%
baraka

Subscribe now for daily local and international financial news

Subscribe